My watch list
my.bionity.com  
Login  

2 Current news of Actelion

rss
matching the following criteria

Actelion and Roche enter into autoimmune disorder collaboration

19-07-2006

Actelion Ltd and Roche have announced today that they have entered into an exclusive worldwide collaboration to jointly develop and commercialize Actelion's selective S1P1 receptor agonist, an immunomodulator with the potential for once-a-day oral dosing. The compound is currently being developed ...

more

Actelion receives USD 7 million following entry into man of a new renin inhibitor

Actelion/Merck Renin alliance achieves third milestone

07-07-2006

Actelion Ltd. announced that the renin alliance with Merck & Co., Inc., has achieved its third milestone. The alliance has entered into man its first compound, a new renin inhibitor. This start of full clinical development triggers a milestone payment by Merck to Actelion of USD 7 ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE